Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells

Abstract excerpt

// Bing Z. Carter 1 , Po Yee Mak 1 , Duncan H. Mak 1 , Vivian R. Ruvolo 1 , Wendy Schober 1 , Teresa McQueen 1 , Jorge Cortes 2 , Hagop M. Kantarjian 2 , Richard E. Champlin 3 , Marina Konopleva 1 and Michael Andreeff 1 1 Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2 Department of Leukemia, The University of Texas MD...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Chronic Lymphocytic Leukemia Research
• Share to Chronic Myeloid Leukemia Treatments